Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 9.50p on 24-12-2025 at 19:30:04
Change 0.00p 0%
Buy 10.00p
Sell 9.00p
Last Trade: Buy 4,000.00 at 9.95p
Day's Volume: 0
Last Close: 9.50p
Open: 9.50p
ISIN: VGG042401262
Day's Range 9.50p - 9.50p
52wk Range: 6.25p - 29.00p
Market Capitalisation: £4.91m
VWAP: 0.00p
Shares in Issue: 51.74m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 4,000 9.95p Ordinary
16:22:06 - 23-Dec-25
Buy* 2,010 9.95p Ordinary
11:59:00 - 23-Dec-25
Sell* 7,222 9.41p Ordinary
11:41:32 - 23-Dec-25
Sell* 200 9.00p Ordinary
11:41:03 - 23-Dec-25
Buy* 590 10.00p Ordinary
09:35:37 - 23-Dec-25
Buy* 200 10.00p Ordinary
08:35:14 - 23-Dec-25
Unknown* 50,000 10.00p Ordinary
16:12:42 - 22-Dec-25
Sell* 492 9.82p Ordinary
11:27:13 - 22-Dec-25
Unknown* 29,950 10.00p Ordinary
09:11:51 - 22-Dec-25
Sell* 10,256 9.751p Ordinary
09:02:09 - 22-Dec-25
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
24th Dec 2025 (Wed) 9.50 9.50 9.50 9.50 0
23rd Dec 2025 (Tue) 9.50 9.50 9.50 9.50 14,289
22nd Dec 2025 (Mon) 9.50 10.00 9.50 9.50 307,688
19th Dec 2025 (Fri) 9.50 9.50 9.50 9.50 536,630
18th Dec 2025 (Thu) 10.00 10.00 9.50 9.50 330,374
17th Dec 2025 (Wed) 8.75 10.00 8.75 10.00 1,117,197
16th Dec 2025 (Tue) 8.75 8.75 8.75 8.75 9,349
15th Dec 2025 (Mon) 8.75 8.75 8.75 8.75 101,013
12th Dec 2025 (Fri) 8.75 8.75 8.75 8.75 53,429
11th Dec 2025 (Thu) 8.75 8.75 8.75 8.75 97,555
10th Dec 2025 (Wed) 9.50 9.50 8.75 8.75 331,949
9th Dec 2025 (Tue) 11.00 11.00 11.00 11.00 0
8th Dec 2025 (Mon) 11.00 11.00 11.00 11.00 102,505
5th Dec 2025 (Fri) 11.00 11.00 11.00 11.00 92,000
4th Dec 2025 (Thu) 12.00 12.00 11.00 11.00 25,062
3rd Dec 2025 (Wed) 12.00 12.00 12.00 12.00 3,175
2nd Dec 2025 (Tue) 12.00 12.00 12.00 12.00 5,307
1st Dec 2025 (Mon) 12.00 12.00 12.00 12.00 206
28th Nov 2025 (Fri) 12.00 12.00 12.00 12.00 45,636
27th Nov 2025 (Thu) 12.00 12.00 12.00 12.00 26,198
26th Nov 2025 (Wed) 12.00 12.00 12.00 12.00 70,974
25th Nov 2025 (Tue) 12.00 12.00 12.00 12.00 14,978
24th Nov 2025 (Mon) 12.00 12.00 12.00 12.00 10,266
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
15th Dec 2025 2:29 pm RNS Result of Retail Offer
10th Dec 2025 7:25 am RNS Retail Offer
10th Dec 2025 7:00 am RNS Placing of £1,000,000
27th Nov 2025 7:00 am RNS Holding(s) in Company
30th Oct 2025 7:00 am RNS US Orphan Drug Designation Application
14th Oct 2025 7:00 am RNS Positive Preclinical Data in Prostate Cancer
15th Sep 2025 7:00 am RNS Half Year Report
12th Sep 2025 7:00 am RNS Notice of Interim Results and IMC Presentation
1st Sep 2025 7:00 am RNS Approval for phase 2 clinical trial
26th Aug 2025 4:03 pm RNS Result of AGM
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

TRADING UPDATES: Netcall acquires Jadu for up to GBP19 million

10th Dec 2025 16:16

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

CRISM reports "significant" preclinical data for prostate cancer drug

14th Oct 2025 16:50

(Alliance News) - CRISM Therapeutics Corp said on Tuesday that preclinical studies show that its ChemoSeed drug delivery platform could "could substantially enhance" the efficacy of docetaxel in the treatment of prostate cancer. Read More

EARNINGS: CRISM loss widens as "actively" prepares for phase 2 trial

15th Sep 2025 21:41

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: CRISM confident in ChemoSeed as targets trial approval

26th Aug 2025 13:56

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - As the firm held its annual general meeting, Chair Nermeen Varawalla says the firm must attract, retain and incentivise the best people as it continues to seek further validation for its novel delivery method. "[We] are confident that ChemoSeed has the potential to transform treatment for patients with solid-tumour cancers," Chair Varawalla continues. ChemoSeed is an implantable biodegradable drug delivery technology designed for the sustained delivery of chemotherapy directly into cancer tissue. Chair Varawalla says the company is focused on gaining trial approval from the UK Medicines & Healthcare products Regulatory Agency in glioblastoma and progressing towards dosing first patients in early 2026. Read More

UK shareholder meetings calendar - next 7 days

19th Aug 2025 14:58

Read More

See more Crism Thera news
FTSE 100 Latest
Value9,870.68
Change-18.54

Login to your account

Forgot Password?

Not Registered